225
Participants
Start Date
July 12, 2022
Primary Completion Date
June 2, 2028
Study Completion Date
June 2, 2028
GT005
GT005 is a gene therapy for GA and is a recombinant adeno-associated viral serotype 2 (AAV2) vector encoding for human complement factor I. GT005 was administered to all participants in an antecedent study prior to enrollment in ORACLE and GT005 is not administered in the ORACLE study.
The University of Melbourne - The Centre for Eye Research Australia (CERA), Melbourne E.
Columbia University Medical Center, New York
Retina Associates of Western New York, Rochester
Mid Atlantic Retina - Wills Eye Hospital, Philadelphia
CHU Dijon - Hopital Mitterrand, Dijon
The Retina Care Center, Llc - Baltimore Location, Baltimore
Universitaetsklinikum Schleswig-Holstein, Lübeck
Clinica Baviera, Madrid
Clinica Universidad de Navarra - Pamplona, Pamplona
Rand Eye Institute, Inc. (Rei), Pompano Beach
Retina Vitreous Associates of Florida, St. Petersburg
CHU de Nantes - Hôtel-Dieu, Nantes
Cincinnati Eye Institute, Cincinnati
Midwest Eye Institute Northside, Indianapolis
Wolfe Eye Clinic, West Des Moines
Pepose Vision Institute, P.C - Midwest Vision Research Foundation, Chesterfield
Universitaetsklinikum Tuebingen, Tübingen
Texas Retina Associates (Tra) - Dallas Main, Dallas
Retina Consultants of Texas (Retina Consultants of Houston) - Texas Medical Center, Houston
Retinal Consultants of San Antonio (Rcsa) - Medical Center, San Antonio
Retina Consultants of Austin, Austin
Southwest Retina Research Center, Durango
Sierra Eye Associates, Reno
Retina Consultants San Diego - Poway, Poway
Vitreo Retinal Associates Pa - the Millennium Center Location, Gainesville
University Retina and Macula Associates, P.C. - Lemont Office, Lemont
Ophthalmic Consultants of Boston (OCB), Boston
Sterling Vision - Oregon Retina, Llp, Eugene
Retina Consultants of Texas (Retina Consultants of Houston) - Texas Medical Center, Houston
Instituto de microcirugía ocular, Barcelona
The Retina Clinic London, London
South Tyneside and Sunderland Nhs Foundation Trust - Sunderland Eye Infirmary, Sunderland
Lead Sponsor
Collaborators (1)
Novartis Pharmaceuticals
INDUSTRY
Gyroscope Therapeutics Limited
INDUSTRY